A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

However, typically, type 2 diabetes is treated with medication plus lifestyle modifications. The following article includes ...

More than 36 million Americans have type 2 diabetes, a condition primarily attributed to the body's cells not responding to ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

The cohort comprised adults age 40 and older with type 2 diabetes who initiated treatment with an SGLT2 inhibitor, DPP-4 inhibitor, or GLP-1 receptor agonist after 2013 and who had active COPD as ...

Now, an analysis of studies has found that newer medications for type 2 diabetes may help reduce the risk of complications, particularly cardiovascular disease, in some people with type 2 diabetes.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Millions with type 2 diabetes face hidden nutrient deficiencies, raising concerns about health risks and the urgent need for dietary intervention.

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

People with diabetes are more prone to developing Staphylococcus aureus, a leading cause of infections and death associated ...